{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:31:16Z","timestamp":1790742676030,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T00:00:00Z","timestamp":1712620800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.vaccine.2024.04.014","type":"journal-article","created":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T10:34:26Z","timestamp":1713177266000},"page":"3230-3238","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Antibody kinetics between birth and three months of life in healthy infants with natural exposure to Group B streptococcus: A UK cohort study"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5313-9482","authenticated-orcid":false,"given":"Konstantinos","family":"Karampatsas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9001-6684","authenticated-orcid":false,"given":"Tom","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merryn","family":"Voysey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9068-3233","authenticated-orcid":false,"given":"Clara","family":"Carreras-Abad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0436-4843","authenticated-orcid":false,"given":"Madeleine","family":"Cochet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laxmee","family":"Ramkhelawon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4504-2979","authenticated-orcid":false,"given":"Elisabeth","family":"Peregrine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7540-7433","authenticated-orcid":false,"given":"Paul T.","family":"Heath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsty","family":"Le Doare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.04.014_b0005","doi-asserted-by":"crossref","first-page":"e807","DOI":"10.1016\/S2214-109X(22)00093-6","article-title":"Group B streptococcus infection during pregnancy and infancy: estimates of regional and global burden","volume":"10","author":"Gon\u00e7alves","year":"2022","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.vaccine.2024.04.014_b0010","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S2352-4642(21)00022-5","article-title":"Mortality, neurodevelopmental impairments, and economic outcomes after invasive group B streptococcal disease in early infancy in Denmark and the Netherlands: a national matched cohort study","volume":"5","author":"Horv\u00e1th-Puh\u00f3","year":"2021","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.vaccine.2024.04.014_b0015","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1001\/jamapediatrics.2018.4826","article-title":"Epidemiology of invasive early-onset and late-onset group b streptococcal disease in the United States, 2006 to 2015: multistate laboratory and population-based surveillance","volume":"173","author":"Nanduri","year":"2019","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.vaccine.2024.04.014_b0020","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1093\/cid\/cix660","article-title":"Maternal disease with group B streptococcus and serotype distribution worldwide: systematic review and meta-analyses","volume":"65","author":"Hall","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2024.04.014_b0025","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1093\/cid\/cix585","article-title":"Stillbirth with group B streptococcus disease worldwide: systematic review and meta-analyses","volume":"65","author":"Seale","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2024.04.014_b0030","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1586\/14760584.2014.953939","article-title":"Review on the association of group B streptococcus capsular antibody and protection against invasive disease in infants","volume":"14","author":"Dangor","year":"2014","journal-title":"Expert Rev Vacc"},{"key":"10.1016\/j.vaccine.2024.04.014_b0035","doi-asserted-by":"crossref","first-page":"7391","DOI":"10.1016\/j.vaccine.2017.09.087","article-title":"Maternal immunization against Group B streptococcus: World Health Organization research and development technological roadmap and preferred product characteristics","volume":"37","author":"Vekemans","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.04.014_b0040","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1056\/NEJM197604012941404","article-title":"Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection","volume":"294","author":"Baker","year":"1976","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2024.04.014_b0045","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1086\/422756","article-title":"Level of maternal IgG anti-group B streptococcus type III antibody correlated with protection of neonates against early-onset disease caused by this pathogen","volume":"190","author":"Lin","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.04.014_b0050","doi-asserted-by":"crossref","first-page":"6793","DOI":"10.1016\/j.vaccine.2015.10.019","article-title":"Correlates of protection of serotype-specific capsular antibody and invasive group B streptococcus disease in South African infants","volume":"33","author":"Dangor","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.04.014_b0055","doi-asserted-by":"crossref","first-page":"e1170","DOI":"10.1093\/cid\/ciaa1873","article-title":"Association of group B streptococcus (GBS) serum serotype-specific anticapsular immunoglobulin G concentration and risk reduction for invasive GBS disease in South African infants: an observational birth-cohort","volume":"73","author":"Madhi","year":"2021","journal-title":"Matched Case-Control Study Clin Infec Dis"},{"key":"10.1016\/j.vaccine.2024.04.014_b0060","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1093\/cid\/ciw377","article-title":"The protective value of maternal group B streptococcus antibodies: quantitative and functional analysis of naturally acquired responses to capsular polysaccharides and pilus proteins in european maternal sera","volume":"63","author":"Fabbrini","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2024.04.014_b0065","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/QCO.0000000000000372","article-title":"Placental transfer of antibody and its relationship to vaccination in pregnancy","volume":"30","author":"Calvert","year":"2017","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.vaccine.2024.04.014_b0070","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1600-0897.1996.tb00172.x","article-title":"Evolution of maternofetal transport of immunoglobulins during human pregnancy","volume":"36","author":"Malek","year":"1996","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.vaccine.2024.04.014_b0075","doi-asserted-by":"crossref","first-page":"e12972","DOI":"10.1111\/aji.12972","article-title":"Expression of FcRn receptor in placental tissue and its relationship with IgG levels in term and pre-term newborns","volume":"80","author":"Lozano","year":"2018","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.vaccine.2024.04.014_b0080","first-page":"555","article-title":"Vertically transferred immunity in neonates: mothers","volume":"11","author":"Albrecht","year":"2020","journal-title":"Mecha Mediators Front Immunol"},{"key":"10.1016\/j.vaccine.2024.04.014_b0085","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.3389\/fimmu.2020.01920","article-title":"Update on transplacental transfer of IgG subclasses: impact of maternal and fetal factors","volume":"11","author":"Clements","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2024.04.014_b0090","doi-asserted-by":"crossref","first-page":"e197","DOI":"10.1016\/S1473-3099(17)30229-3","article-title":"Maternal immunisation: collaborating with mother nature","volume":"17","author":"Marchant","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2024.04.014_b0095","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.cell.2019.05.044","article-title":"Fc glycan-mediated regulation of placental antibody transfer","volume":"178","author":"Jennewein","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2024.04.014_b0100","doi-asserted-by":"crossref","first-page":"e162","DOI":"10.1016\/S1473-3099(18)30659-5","article-title":"Serocorrelates of protection against infant group B streptococcus disease","volume":"19","author":"Le Doare","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2024.04.014_b0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta23670","article-title":"Developing a serocorrelate of protection against invasive group B streptococcus disease in pregnant women: a feasibility study","volume":"23","author":"Carreras-Abad","year":"2019","journal-title":"Health Technol Assess (Rockv)"},{"key":"10.1016\/j.vaccine.2024.04.014_b0110","unstructured":"SMI B 58: detection of carriage of group B streptococci - GOV.UK n.d. https:\/\/www.gov.uk\/government\/publications\/smi-b-58-processing-swabs-for-group-b-streptococcal-carriage (accessed February 2, 2023)."},{"key":"10.1016\/j.vaccine.2024.04.014_b0115","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.mimet.2009.11.010","article-title":"A multiplex PCR assay for the direct identification of the capsular type (Ia to IX) of Streptococcus agalactiae","volume":"80","author":"Imperi","year":"2010","journal-title":"J Microbiol Methods"},{"key":"10.1016\/j.vaccine.2024.04.014_b0120","first-page":"12","article-title":"Evaluation of matrix-assisted laser desorption ionisation time-of-flight mass spectrometry (MALDI-TOF MS) for the Identification of group B streptococcus","author":"To","year":"2019","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.vaccine.2024.04.014_b0125","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/infdis\/jiz062","article-title":"A novel hexavalent capsular polysaccharide conjugate vaccine (GBS6) for the prevention of neonatal group B streptococcal infections by maternal immunization","volume":"220","author":"Buurman","year":"2019","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2024.04.014_b0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41541-023-00667-1","article-title":"Calibration of a serum reference standard for Group B streptococcal polysaccharide conjugate vaccine development using surface plasmon resonance","volume":"8","author":"Esadze","year":"2023","journal-title":"Npj Vaccines"},{"key":"10.1016\/j.vaccine.2024.04.014_b0135","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1056\/NEJMoa2116045","article-title":"Potential for maternally administered vaccine for infant group B streptococcus","volume":"389","author":"Madhi","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2024.04.014_b0140","doi-asserted-by":"crossref","first-page":"5850","DOI":"10.1016\/j.vaccine.2017.09.002","article-title":"Prevalence and decay of maternal pneumococcal and meningococcal antibodies: a meta-analysis of type-specific decay rates","volume":"35","author":"Voysey","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.04.014_b0145","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.vaccine.2021.12.007","article-title":"The half-life of maternal transplacental antibodies against diphtheria, tetanus, and pertussis in infants: an individual participant data meta-analysis","volume":"40","author":"Oguti","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.04.014_b0150","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/cei\/uxac066","article-title":"Group B streptococcus (GBS) colonization is dynamic over time, whilst GBS capsular polysaccharides-specific antibody remains stable graphical abstract","volume":"209","author":"Haeusler","year":"2022","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2024.04.014_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2018.12.001","article-title":"Vaginal co-colonization with multiple group B streptococcus serotypes","author":"Khatami","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.04.014_b0160","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.vaccine.2022.11.024","article-title":"Simultaneous carriage of multiple serotypes of group B streptococcus: systematic review and meta-analysis","volume":"41","author":"Barro","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.04.014_b0165","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.1016\/S0264-410X(03)00353-0","article-title":"Immunization of pregnant women with group B streptococcal type III capsular polysaccharide-tetanus toxoid conjugate vaccine","volume":"21","author":"Baker","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.04.014_b0170","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/INF.0000000000000640","article-title":"Relevance of age at diagnosis to prevention of late-onset group B streptococcal disease by maternal immunization","volume":"34","author":"Edwards","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2024.04.014_b0175","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1093\/cid\/cix666","article-title":"Antibody kinetics and response to routine vaccinations in infants born to women who received an investigational trivalent group B streptococcus polysaccharide CRM197-conjugate vaccine during pregnancy","volume":"65","author":"Madhi","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2024.04.014_b0180","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1093\/infdis\/jiv339","article-title":"Kinetics of hemagglutination-inhibiting antibodies following maternal influenza vaccination among mothers with and those without HIV infection and their infants","volume":"212","author":"Nunes","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.04.014_b0185","article-title":"A group B streptococcus alpha-like protein subunit vaccine induces functionally active antibodies in humans targeting homotypic and heterotypic strains","volume":"3","author":"Pawlowski","year":"2022","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.vaccine.2024.04.014_b0190","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1093\/infdis\/jiu316","article-title":"Respiratory syncytial virus transplacental antibody transfer and kinetics in mother-infant pairs in Bangladesh","volume":"210","author":"Chu","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.04.014_b0195","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.2147\/IDR.S203454","article-title":"A vaccine against group B streptococcus: recent advances","volume":"13","author":"Carreras-Abad","year":"2020","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.vaccine.2024.04.014_b0200","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1016\/j.vaccine.2022.05.016","article-title":"Methodology for a correlate of protection for group B streptococcus: report from the bill & melinda gates foundation workshop held on 10 and 11 february 2021","volume":"40","author":"Gilbert","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.04.014_b0205","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.jpeds.2013.05.064","article-title":"Group B streptococcal colonization in 160 mother-baby Pairs: a prospective cohort study","volume":"163","author":"Berardi","year":"2013","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2024.04.014_b0210","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jinf.2015.12.014","article-title":"Risk factors for group B streptococcus colonisation and disease in Gambian women and their infants","volume":"72","author":"Le Doare","year":"2016","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2024.04.014_b0215","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jpeds.2017.07.039","article-title":"Effects of intrapartum antibiotic prophylaxis on neonatal acquisition of group B streptococci","volume":"190","author":"Toyofuku","year":"2017","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2024.04.014_b0220","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1093\/cid\/ciz033","article-title":"Risk factors for infant colonization by hypervirulent CC17 group B streptococcus: toward the understanding of late-onset disease","volume":"69","author":"Tazi","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2024.04.014_b0225","article-title":"The impact of circulating antibody on group b streptococcus intestinal colonization and invasive disease","volume":"89","author":"Vaz","year":"2021","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2024.04.014_b0230","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.3389\/fimmu.2020.595297","article-title":"Understanding early-life adaptive immunity to guide interventions for pediatric health","volume":"11","author":"Semmes","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2024.04.014_b0235","unstructured":"Study Details | Development of a Serocorrelate of Protection Against Invasive Group B Streptococcus Disease | ClinicalTrials.gov n.d. https:\/\/clinicaltrials.gov\/study\/NCT04735419 (accessed November 21, 2023)."},{"key":"10.1016\/j.vaccine.2024.04.014_b0240","doi-asserted-by":"crossref","unstructured":"E. Auma T. Hall S. Chopra S. Bilton L. Ramkhelawon F. Amini et al. Using Dried Blood Spots for a Sero-Surveillance Study of Maternally Derived Antibody against Group B Streptococcus 2023 10.3390\/vaccines11020357.","DOI":"10.3390\/vaccines11020357"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24004286?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24004286?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T19:35:41Z","timestamp":1760816141000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24004286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":48,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S0264410X24004286"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.04.014","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibody kinetics between birth and three months of life in healthy infants with natural exposure to Group B streptococcus: A UK cohort study","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.04.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}